PATH stock closes at $16.03 on 06 Jan 2026: what the price and forecast mean
PATH stock closed at $16.03 on 06 Jan 2026 on the NYSE as the market closed, unchanged from the prior session. The UiPath Inc. (PATH) quote shows a day range $15.61–$16.48, year range $9.38–$19.84, and market cap $9,263,316,308.00. Trading volume settled at 20,021,900.00 versus an average of 30,453,681.00, leaving the stock near its 50-day average of $15.60. Below we run focused PATH stock analysis across earnings, valuation, technicals, and our model forecast for AI stocks.
PATH stock price snapshot and liquidity
UiPath Inc. (PATH) closed at $16.03 on the NYSE in USD with volume 20,021,900.00 and avg volume 30,453,681.00. The intraday low and high were $15.61 and $16.48 and shares outstanding are 534,679,152.00. Market structure shows relative liquidity but lower-than-average turnover, which can widen moves on AI sector news.
PATH stock earnings and fundamentals
PATH reported trailing EPS $0.42 and a PE near 41.25, with revenue per share TTM $2.88 and free cash flow yield 0.03 (3.39%). UiPath’s current ratio is 2.54, cash per share $2.59, and debt to equity 0.04, indicating a strong liquidity profile despite a premium multiple. Recent financial growth shows revenue growth 23.57% year-over-year and sharper EPS growth, supporting the valuation if growth continues.
PATH stock technicals and short-term trading setup
Technical indicators place PATH stock in neutral territory: RSI 48.89, MACD histogram -0.15, ATR 0.89, and ADX 21.59, implying modest trend strength. Bollinger Bands sit $14.79 (lower) to $19.20 (upper), with 50-day average $15.60 and 200-day average $13.08. Traders should watch a break above $17.00 for momentum or a drop below $15.00 for added downside risk.
PATH stock valuation and analyst view
Analyst consensus lists a median price target $16.00 and a consensus target $15.71 (range $12.00–$19.00). The broker mix is mostly Hold: 1 Buy, 10 Hold, and company rating services flagged a C / Sell opinion on 2025-02-28. Key valuation metrics: P/S 5.92, P/B 4.81, EV/Revenue 5.49, which shows PATH stock trades at premium multiples vs many software peers.
PATH stock Meyka AI grade and model forecast
Meyka AI rates PATH with a score of 72.95 out of 100 (Grade: B+, Suggestion: BUY). This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecast models. Meyka AI’s forecast model projects monthly $16.45, quarterly $18.51, and yearly $15.03. These projections imply a monthly upside 4.26%, quarterly upside 15.48%, and yearly downside -6.19% versus the current $16.03. Forecasts are model-based projections and not guarantees.
PATH stock risks, AI sector context, and opportunities
UiPath competes in Software – Infrastructure with strong AI and RPA demand, which is an opportunity for growth in banking, healthcare, and government. Risks include high valuation multiples, days sales outstanding 116.59, and a tilted analyst view (mostly Hold). Sector rotation, slower enterprise spending, or execution slippage on Automation Cloud could pressure PATH stock despite favorable AI adoption trends.
Final Thoughts
Key takeaways for PATH stock: UiPath closed at $16.03 on 06 Jan 2026 on the NYSE with solid liquidity metrics but below-average volume. Fundamental strength includes EPS $0.42, current ratio 2.54, and consistent revenue growth of 23.57% year-over-year, but PATH trades at premium multiples (PE 41.25, P/S 5.92, P/B 4.81) that leave limited margin for execution misses. Analyst median target $16.00 aligns closely with the current price, while Meyka AI’s model projects a quarterly target of $18.51 (implied upside 15.48%) and a year target of $15.03 (implied downside -6.19%). Investors focused on AI stocks should weigh UiPath’s product momentum and cash position against valuation and receivables risk. For active traders, a breakout above $17.00 would be constructive; longer-term investors should monitor upcoming earnings and guidance on 11 Mar 2026. Meyka AI provides this as AI-powered market analysis; forecasts are model-based projections and not guarantees.
FAQs
PATH stock closed at **$16.03** on 06 Jan 2026 on the NYSE. Day range was **$15.61–$16.48** with volume **20,021,900.00**. The stock traded near its 50-day average **$15.60**.
Analyst consensus for PATH stock shows a median price target **$16.00** and consensus **$15.71**. Broker coverage is mostly Hold with **1 Buy** and **10 Hold** ratings, signaling cautious optimism.
Main risks for PATH stock include high valuation multiples (PE **41.25**), long receivables (DSO **116.59**), and sensitivity to enterprise IT spending. Competition and execution on cloud AI offerings are additional risks.
Meyka AI’s forecast model projects monthly **$16.45**, quarterly **$18.51**, and yearly **$15.03** for PATH stock. These are model-based projections and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
